Aller au contenu principal

 Articles scientifiques

[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant.

Auteurs : Iqbal R, Yaqub M, Bektas HO, Oprea-Lager DE, de Vries EGE, Glaudemans AWJM, Aftimos P, Gebhart G, Beelen AP, Schuit RC, Windhorst AD, Boellaard R, Menke-van der Houven van Oordt CW
Année : 2023
Journal : Clin Cancer Res

Lymphatic Alterations Under Tattoos: Preliminary Reports of One Observational Study.

Auteurs : Bourgeois P, Roman MM, Schweicher J, Lavoisier P, Maquet P, Karler C, Lizewski M, Fouarge A, Cuylits N, Del Marmol V, Leduc O
Année : 2023
Journal : Clin Cosmet Investig Dermatol
Volume : 16
Pages : 257-265

PIK3CA copy number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer.

Auteurs : Amato O, Buisseret L, Gebhart G, Plouznikoff N, Larsimont D, Awada A, Piccart M, Aftimos P
Année : 2023
Journal : Cold Spring Harb Mol Case Stud

Lymphoscintigraphic Investigations for Axillary Web Syndromes.

Auteurs : Roman MM, Barbieux R, Eddy C, Karler C, Veys I, Zeltzer A, Adriaenssens N, Leduc O, Bourgeois P
Année : 2022
Journal : Lymphat Res Biol
Volume : 20
Pages : 417-424

(68)Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy.

Auteurs : Shagera QA, Artigas C, Karfis I, Critchi G, Chanza NM, Sideris S, Peltier A, Paesmans M, Gil T, Flamen P
Année : 2022
Journal : J Nucl Med
Volume : 63
Pages : 1191-1198

Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

Auteurs : Gombos A, Venet D, Ameye L, Vuylsteke P, Neven P, Richard V, Duhoux FP, Laes JF, Rothe F, Sotiriou C, Paesmans M, Awada A, Guiot T, Flamen P, Piccart-Gebhart M, Ignatiadis M, Gebhart G
Année : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pages : 38

Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant.

Auteurs : Malorni L, Tyekucheva S, Hilbers FS, Ignatiadis M, Neven P, Colleoni M, Henry S, Ballestrero A, Bonetti A, Jerusalem G, Papadimitriou K, Bernardo A, Seles E, Duhoux FP, Macpherson IR, Thomson A, Davies DM, Bergqvist M, Migliaccio I, Gebhart G, Zoppoli G, Bliss JM, Benelli M, McCartney A, Kammler R, De Swert H, Ruepp B, Fumagalli D, Maibach R, Cameron D, Loi S, Piccart M, Regan MM
Année : 2022
Journal : Eur J Cancer
Volume : 164
Pages : 39-51

EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.

Auteurs : Weber M, Lam M, Chiesa C, Konijnenberg M, Cremonesi M, Flamen P, Gnesin S, Bodei L, Kracmerova T, Luster M, Garin E, Herrmann K
Année : 2022
Journal : Eur J Nucl Med Mol Imaging
Volume : 49
Pages : 1682-1699

The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma.

Auteurs : Rodríguez-Fraile M, Tamayo Alonso P, Rosales JJ, de Arcocha-Torres M, Caresia-Aróztegui AP, Cózar-Santiago MP, Orcajo-Rincon J, Simó Perdigó M, Delgado Bolton RC, Artigas C
Année : 2022
Journal : Rev Esp Med Nucl Imagen Mol (Engl Ed)
Volume : 41
Pages : 126-135

An Atypical Behavior of Metastatic Lung Disease in a Young Woman With Osteosarcoma: A Case Report.

Auteurs : Acquisto A, Duran Derijckere I, De Angelis R
Année : 2022
Journal : Cureus
Volume : 14
Pages : e21589

Suspicious cold thyroid nodule with intense focal 68Ga-DOTATATE uptake: a case report.

Auteurs : Manta R, Delbart W, Duran Derijckere I, Quiriny M, Demetter P, Flamen P, Karfis I
Année : 2022
Journal : Eur J Hybrid Imaging
Volume : 6
Pages : 8

Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study.

Auteurs : Pérez-García JM, Gebhart G, Borrego MR, Schmid P, Marmé F, Prat A, Dalenc F, Kerrou K, Colleoni M, Braga S, Malfettone A, Sampayo-Cordero M, Cortés J, Llombart-Cussac A
Année : 2022
Journal : Future Oncol
Volume : 18
Pages : 3677-3688

Intraoperative electron radiotherapy in early invasive ductal breast cancer: 6-year median follow-up results of a prospective monocentric registry.

Auteurs : Philippson C, Larsen S, Simon S, Vandekerkhove C, De Caluwe A, Van Gestel D, Chintinne M, Veys I, De Neubourg F, Noterman D, Roman M, Nogaret JM, Desmet A
Année : 2022
Journal : Breast Cancer Res
Volume : 24
Pages : 83

Dual [(68)Ga]DOTATATE and [(18)F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.

Auteurs : Chan DL, Hayes AR, Karfis I, Conner A, Furtado OMahony L, Mileva M, Bernard E, Roach P, Marin G, Pavlakis N, Schembri G, Gnanasegaran G, Marin C, Vanderlinden B, Navalkissoor S, Caplin ME, Flamen P, Toumpanakis C, Bailey DL
Année : 2022
Journal : Br J Cancer
Volume : 128
Pages : 549-55

Use of fluorescence imaging during lymphatic surgery: A Delphi survey of experts worldwide.

Auteurs : Dip F, Alexandru N, Amore M, Becker C, Belgrado JP, Bourgeois P, Chang EI, Koshima I, Liberale G, Masia J, Mortimer P, Neligan P, Batista BN, Olszewski W, Salvia SA, Suami H, Vankerckhove S, Yamamoto T, Lo Menzo E, White KP, Rosenthal RJ
Année : 2022
Journal : Surgery
Volume : 172
Pages : S14-S20

The Impact of Temporal Variation in ICG Administration on Axillary Node Identification During Reverse Mapping Procedures.

Auteurs : Roman MM, Nogaret JM, Veys I, Delrue P, Eddy C, Karler C, Marmol VD, Bourgeois P
Année : 2022
Journal : Chirurgia (Bucur)
Volume : 117
Pages : 305-311

Circulating DNA in the neoadjuvant setting of early stage colon cancer.

Auteurs : Bregni G, Pretta A, Senti C, Acedo Reina E, Vandeputte C, Trevisi E, Gkolfakis P, Kehagias P, Deleporte A, Van Laethem JL, Vergauwe P, Van den Eynde M, Deboever G, Janssens J, Demolin G, Holbrechts S, Clausse M, De Grez T, Peeters M, DHondt L, Geboes K, Besse-Hammer T, Rothé F, Flamen P, Hendlisz A, Sclafani F
Année : 2022
Journal : Acta Oncol
Volume : 61
Pages : 1223-1229

Understanding the Radiobiological Mechanisms Induced by (177)Lu-DOTATATE in Comparison to External Beam Radiation Therapy.

Auteurs : Delbart W, Karabet J, Marin G, Penninckx S, Derrien J, Ghanem GE, Flamen P, Wimana Z
Année : 2022
Journal : Int J Mol Sci
Volume : 23

Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.

Auteurs : Woff E, Salvatore L, Marmorino F, Genovesi D, Critchi G, Guiot T, Ameye L, Sclafani F, Hendlisz A, Flamen P
Année : 2022
Journal : J Nucl Med
Volume : 63
Pages : 549-555

FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

Auteurs : Gombos A, Venet D, Ameye L, Vuylsteke P, Neven P, Richard V, Duhoux FP, Laes JF, Rothe F, Sotiriou C, Paesmans M, Awada A, Guiot T, Flamen P, Piccart-Gebhart M, Ignatiadis M, Gebhart G
Année : 2021
Journal : NPJ Breast Cancer
Volume : 7
Pages : 125